Press and News

iOmics Lifesciences, Withings, and Be All Concepts announced the launch of the Precision Health Management – Monitoring solution, dedicated to bringing a new personalized health management experience to Hong Kong people. This initiative shifts the health paradigm from “passive treatment” to “proactive prevention,” enabling individuals to understand and manage their own health risks, embodying the modern medical philosophy that prevention is better than cure. In recent years, the trend of younger onset of critical illnesses such as heart disease, stroke, diabetes, and cancer has become increasingly serious. The traditional “treat only when sick” model is no longer sufficient to address today’s health challenges. The Precision Health Management – Monitoring solution integrates advanced Multi-Omics analysis, AI algorithms, and real-time health data to provide scientifically grounded, personalized health management recommendations for individuals and communities, fundamentally reducing chronic disease risks. Real-time health monitoring is an indispensable component of precision health management. This initiative combines iOmics Lifesciences' cutting-edge Multi-Omics profiling – which analyzes genomic, proteomic and metabolic biomarkers to identify hidden health risks 3-5 years before disease onset – with Withings' FDA-cleared/CE-certified Withings Remote Patient Monitoring (WRPM) devices. These devices connect households to a medical-grade cloud platform compliant with EU General Data Protection Regulation (GDPR), providing clinical-grade health management and professional follow-up services. This collaboration will enable seamless 24-hour home health monitoring with professional medical support. Crucially, iOmics Lifesciences' AI-driven analytics platform will integrate with Withings' continuous physiological data into personalized risk alerts and prevention strategies, establishing Hong Kong's first precision health management system that proactively intercepts disease pathways.   "Precision Health Management – Monitoring": Realizing a New Medical Paradigm of Disease Prevention Through Technology Step 1: Multi-Omics testing - the key technology for interpreting the body’s early warning signals. iOmics Lifesciences strictly adopts medical-grade Whole Genome Sequencing (WGS) as the sole technical standard, covering 3 billion DNA base pairs in the human genome. At the same time, it integrates comprehensive biological data including proteomics and metabolomics, enabling the prediction of chronic disease risks such as heart disease, stroke, and diabetes 5 to 10 years in advance. This creates a unique “Personal Body User Manual” for each user. This manual not only reveals innate health vulnerabilities but also provides precise prevention strategies, empowering individuals to proactively manage their health. Step 2: Establish Personalized Health Monitoring with Withings RPM Withings’ medical-grade devices provide real-time data, allowing for home-based monitoring to be completed in three minutes, eliminating the need for multiple clinic visits. Key applications cover Cardiovascular Health, Diabetes and Obesity Management, Mental Health Indicators, and Physical Activity. Real-time data can be used to formulate health plans, identify early risks, develop personalized prevention strategies, and for population health and family risk planning. The solution provides personalized health profiles that meet over 82.9% of users’ health insight needs (as shown in co-management studies), enabling early detection and prevention of cardiovascular disease (CVD), type 2 diabetes (T2D), and even certain cancers – the latter accounting for nearly 30% of total mortality. This supports real prevention and improves quality of life for aging populations. The press conference guest Dr. Stephen Lam Tak Sum, a pioneer in genetic research and esteemed clinical geneticist, who provided in-depth insights on future trends in health management, “With the advancement of AI and data technology, health management is shifting from reactive treatment to proactive prevention – focusing on personalization and continuous monitoring. As the population ages, comprehensive bioinformatics, including genomics and proteomics, will become extremely important. The combination of these technologies will enable us to gain a more comprehensive understanding of the nature of diseases, thereby developing more effective prevention methods. This is an exciting era where we have the opportunity to transform the face of healthcare through technology. We look forward to achieving more breakthroughs in this field and contributing to global health endeavors." Mr. Johnny Li, CEO and Founder of iOmics Lifesciences, stated, “By combining multi-omics technology with AI analysis, we will be able to precisely decode the pre-disease state and identify health risks before clinical symptoms appear. However, this is only the first step in precision health management. Today, we are honored to collaborate with Withings and Be All Concepts to jointly establish a comprehensive network that combines 'Detection + Monitoring + Services,' providing Hong Kong people with scientific and personalized health management solutions. This is an important step in driving Hong Kong's health transformation." Mr. Duncan Yu, General Manager (Asia), Withings, a leading French medical health company, said: “Withings is committed to building a user-centered smart health ecosystem. We are very pleased to collaborate with iOmics Lifesciences and Be All Concepts. Through the WRPM solution, professional healthcare providers can utilize our medical-grade devices and EU GDPR-compliant medical cloud platform to enable Hong Kong users to gain a more comprehensive understanding of their health status, achieving true preventive health management.” Mr. Stephen Chen, Co-founder of Be All Concepts, explained: “Our cross-sector collaboration responds to Hong Kong society’s urgent need for chronic disease prevention and health promotion. By combining technology with professional services, we aim to promote healthy living and empower individuals with autonomous health data, creating a proactive and healthy future. Our goal is to bring lifelong medical innovation to every individual and to an aging society.” Dr. Norman Chan, a renowned endocrinologist and diabetes specialist in Hong Kong, stated, “Prevention is the future of chronic disease management. By leveraging advanced home-use medical devices for precise physiological measurements, combined with medical grade whole genome sequencing, we can identify high-risk individuals at an early stage. With the support of AI, these individuals can be guided to take preventive actions and implement proper health management before any complications arise—ultimately reducing the likelihood of chronic disease development.” According to the survey of the Centre for Health Protection, over 67% of respondents have health risks such as high cholesterol, heart disease, and stroke, yet lack effective self-management tools. This cross-sector collaboration promotes Precision Health Management - Monitoring as a preventive approach, offering a comprehensive and scalable solution for chronic disease prevention and health management. The solution has been clinically validated and verified by medical institutions, ensuring safe and effective support for users. It directly addresses a critical public health pain point and brings breakthrough progress in preventive care and chronic disease management. About iOmics Lifesciences Founded in 2024, iOmics Lifesciences is a Hong Kong Science Park Incubation Programme company. Our professional team consists of clinical geneticists, board certified genetic counsellor, bioinformaticians, laboratory scientists, nutritionists, and a strong AI development team. We are dedicated to deeply integrating multi-omics data through proprietary AI technology, breaking down medical data silos and unleashing the full potential of health data. We provide patients and healthcare providers with a more personalized, intelligent, and timely health management experience. Through the dual-core strategy of “Precision Testing + Intelligent Prevention,” we create a unique “Personal Body User Manual” for every user, empowering individuals with the knowledge and ability to prevent diseases and safeguarding every life. About Withings Withings was founded in France in 2008. We focus on developing medical-grade products that combine advanced technology with elegant design, integrating the concept of smart health into users’ daily lives to provide more comprehensive health monitoring and lasting improvements. Withings products are clinically validated and award-winning, with millions of users worldwide. Withings RPM brings together the necessary resources through a one-stop platform for user management, delivering a better experience to users. About Be All Concepts Be All Concepts Limited is the exclusive Withings Authorized Health Solutions Provider and exclusive distributor of WITHINGS consumer products in Hong Kong and Macau. Leveraging over 24 years of combined professional knowledge and extensive experience in both B2B and B2C markets from its two founders, we are committed to delivering efficient and impactful solutions through strategic deployment and precise execution. For media enquiries & interview requests, please contact Say It LOUD Company Venus Wong on 6046 5327 or Crystal Chan on 9468 6388